Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists
Satoshi Yamamoto(Takeda (Japan)), Mitsuhiro Ito(Takeda (Japan)), Tomohiro Kaku(Takeda (Japan)), Atsushi Hasuoka(Takeda (Japan)), Naoyuki Kanzaki, Takahito Hara(Takeda (Japan)), Hiromi Kobayashi(Kyushu University), Atsuo Baba(Takeda (Japan)), Masuo Yamaoka, Katsuji Aikawa(Takeda (Japan))
Cited by 9
Related Papers
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
|PubMed|2003|427
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
|Journal of Medicinal Chemistry|2021|205
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
|Proceedings of the National Academy of Sciences|2018|172
Studies on Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline Derivatives and Their Anti-inflammatory Effect
|Journal of Medicinal Chemistry|1996|151